MOH — Stock Film
STOCK FILMSCENE 1/11MOH · $203
Stock Expert AI presents
MOH
Molina Healthcare, Inc
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
Molina Healthcare, Inc. What it actually does.

Provides managed healthcare services to low-income families and individuals. Administers healthcare benefits under Medicaid programs. Now — the numbers.

on the stock market since 2003
19K employees
$11B market value
WHERE DOES THE MONEY COME FROM?
75%Medicaid Solutions
Medicaid SolutionsMedicare 14%Marketplace 10%Other <1%
75% of all revenue comes from a single line: Medicaid Solutions.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

Revenue last year:
$45B
The net profit left over:
$472M
Out of every $100 in sales, $1 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 1%

This is an established company with proven profits.

THE PRICE TAG
MARKET VALUE / ANNUAL PROFIT
22.4×

The market pays 22.4× for every dollar of annual profit — around what a business like this usually costs.

Against companies in its own sector, it looks cheaper than 79% of them.

Analysts' average target sits 1% above today's price.

What executives did with their own stock over the last 12 months:
46 buy12 sell

Executives buying with their own money is usually read as confidence in the company’s future.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
83
very strong

Profit power and business quality lead the class.

FINANCIAL STRENGTH
45
weak

Clearly below the class average.

VALUATION
79
strong

Clearly above the class average — a step short of the very top.

GROWTH
37
weak

Clearly below the class average.

PRICE MOMENTUM
69
strong

Clearly above the class average — a step short of the very top.

WORTH WATCHING

Growth: Sales growth trails the sector average.

Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.

THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 52% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/3
Sales keep climbing

Over the last 4 years, sales grew about 13% a year on average.

2
THE BRIGHT SIDE · 2/3
Strong cash, light debt

There is $8.3B in the vault; even if every debt were paid off, $4.3B would remain.

3
THE BRIGHT SIDE · 3/3
Executives are buying their own stock

Over the last 12 months, company executives reported 46 buys and 12 sells. Management buying with its own money is usually read as a good sign.

1
THE RISKS · 1/3
Growth trails the sector

The growth engine is running at low revs right now. Report-card grade: 37/100.

2
THE RISKS · 2/3
A thin financial cushion

The balance sheet offers little cushion against a rough stretch. Report-card grade: 45/100.

3
THE RISKS · 3/3
Costs eat into the margin

Costs swallow the gains that sales growth brings in.

FINALE · THE GRADE
A
71 / 100 · MoonshotScore

On our five-subject report card, MOH sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.

The takeaway: MOH is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Sep 11, 2026 · stockexpertai.com · Stock Film